Celeste Lebbè (Céleste Lebbé, Celeste Lebbe, Celeste Lebbé, Céleste Lebbe)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Topics

Squamous Cell Carcinoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

NPJ precision oncology

Journal of the European Academy of Dermatology and Venereology : JEADV

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Idoudi Safa, Maxime Battistella, Perla El Zeinaty, Clara Tavernier, Celeste Lebbè, Baryour Baroudijian
Line-field confocal optical coherence tomography in vivo description of Sarcoptes scabiei and histological correlation. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Paolo Antonio Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero Bermejo, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial. Nature communications 15 (1) (2024)
Paolo Antonio Ascierto, Milena Casula, Jenny Bulgarelli, Marina Pisano, Claudia Piccinini, Luisa Piccin, Antonio Cossu, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Miriam Paone, Maria Grazia Vitale, Ignacio Melero Bermejo, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni, Giuseppe Palmieri
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial. Nature communications 15 (1) (2024)
Idoudi Safa, Maxime Battistella, Perla El Zeinaty, Clara Tavernier, Celeste Lebbè, Baryour Baroudijian
Line-field confocal optical coherence tomography in vivo description of Sarcoptes scabiei and histological correlation. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Chloé Grolleau, Anouk Walter Petrich, Nicolas Dupin, Johan Chanal, Ouidad Zehou, Claire Montlahuc, Baryour Baroudijian, Laetitia Da Meda, Matthieu Resche-Rigon, Laurence Le Cleach, Celeste Lebbè
Effectiveness and safety of major systemic treatments in classic and endemic Kaposi sarcoma: a multicentre retrospective study of 110 patients. The British journal of dermatology 190 (5) (2024)
Sandra P D' Angelo, Celeste Lebbè, Paul T Nghiem, Andrew S Brohl, Thomas Mrowiec, Trent Leslie, Sara Georges, Güelseren Güezel, Parantu Shah
Biomarker analyses investigating disease biology and associations with outcomes in the JAVELIN Merkel 200 trial of avelumab in metastatic Merkel cell carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Robin Zagala, Stéphane Dalle, Marie Beylot-Barry, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbè, Ouidad Zehou, Mona Amini-Adle, Jean-Jacques Grob, Jean-Philippe Arnault, Julia Sanchez, Florence Granel-Brocard, Bernard Cribier, Gaelle Quereux, Florence Brunet-Possenti, Sophie Dalac, Olivier Dereure, Elodie Drumez, Laurent Mortier, Maxime Battistella, Thomas Jouary
Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology : JEADV (2024)
Helen J Gogas, Shruthi Ravimohan, Antara Datta, Aparna Chhibber, Eva Muñoz Couselo, Paulino Tallón de Lara, Caio Pereira, Gaëlle Quéreux, Shahneen Sandhu, Brendan D Curti, Nikhil I Khushalani, Matthew H Taylor, Gregory A Daniels, Anna Spreafico, Tarek Meniawy, Alfons J M Van Den Eertwegh, Yongliang Sun, Yull Arriaga, Ming Zhou, Georgina V Long, Celeste Lebbè
Baseline biomarkers of efficacy and on-treatment immune-profile changes associated with bempegaldesleukin plus nivolumab. NPJ precision oncology 8 (1) (2024)
Caroline Robert, Celeste Lebbè, Thierry Lesimple, Eija Lundström, Valérie Nicolas, Bruno Gavillet, Philippa Crompton, Baryour Baroudijian, Émilie Routier, Ferdy J Lejeune
Phase I Study of Androgen Deprivation Therapy in Combination with Anti-PD-1 in Melanoma Patients Pretreated with Anti-PD-1. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (5) (2023)
Adi Diab, Helen J Gogas, Shahneen Sandhu, Georgina V Long, Paolo Antonio Ascierto, James M G Larkin, Mario Sznol, Fabio Franke, Tudor E Ciuleanu, Caio Pereira, Eva Muñoz Couselo, Fernanda Bronzon Damian, Michael Schenker, Aldo Perfetti, Celeste Lebbè, Gaëlle Quéreux, Friedegund Meier, Brendan D Curti, Carlos Rojas, Yull Arriaga, Haisu Yang, Ming Zhou, Shruthi Ravimohan, Paul Statkevich, Mary A Tagliaferri, Nikhil I Khushalani
Bempegaldesleukin Plus Nivolumab in Untreated Advanced Melanoma: The Open-Label, Phase III PIVOT IO 001 Trial Results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Filippo de Braud, Christophe Dooms, Rebecca S Heist, Celeste Lebbè, Martin Wermke, Anas Gazzah, Dirk Schadendorf, Piotr Lukasz Rutkowski, Juergen Wolf, Paolo Antonio Ascierto, Ignacio Gil-Bazo, Shumei Kato, Maria Wolodarski, Meredith A McKean, Eva Muñoz Couselo, Martin Sebastian, Armando Santoro, Vesselina Cooke, Luca Manganelli, Kitty Wan, Anil Gaur, Jaeyeon Kim, Giordano Caponigro, Xuân-Mai Couillebault, Helen Evans, Catarina D Campbell, Sumit Basu, Michele Moschetta, Adil I Daud
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS -Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Claus Garbe, Reinhard Dummer, Teresa Amaral, Rodabe N Amaria, Paolo Antonio Ascierto, Elizabeth M Burton, Brigitte Dreno, Alexander M M Eggermont, Axel Hauschild, Christoph Hoeller, Roland Kaufmann, Celeste Lebbè, Mario Mandala, Alexander M Menzies, David Moreno, Olivier Michielin, Paul Nathan, Sapna Pradyuman Patel, Caroline Robert, Dirk Schadendorf, Paul C Lorigan, Richard A Scolyer, Hussein A Tawbi, Bart A van de Wiel, Christian U Blank, Georgina V Long
Neoadjuvant immunotherapy for melanoma is now ready for clinical practice. Nature medicine (2023)
Reinhard Dummer, Philippa Corrie, Ralf Gutzmer, Tarek M Meniawy, Michele Del Vecchio, Celeste Lebbè, Michele Guida, Caroline Dutriaux, Brigitte Dreno, Nicolas Meyer, Pier Francesco Ferrucci, Stéphane Dalle, Muhammad Adnan Khattak, Jean-Jacques Grob, Karen Briscoe, James M G Larkin, Sandrine Mansard, Thierry Lesimple, Massimo Guidoboni, Silvia Sabatini, Erika Richtig, Rudolf Herbst, Maurice Lobo, Margarita Askelson, Paolo Antonio Ascierto, Michele Maio
First-Line, Fixed-Duration Nivolumab Plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Caroline Robert, Celeste Lebbè, Thierry Lesimple, Eija Lundström, Valérie Nicolas, Bruno Gavillet, Philippa Crompton, Baryour Baroudijian, Émilie Routier, Ferdy J Lejeune
Phase I study of Androgen deprivation therapy in combination with anti-PD-1 in patients pre- treated with anti-PD-1. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Manon Girod, Stéphane Dalle, Laurent Mortier, Sophie Dalac, Marie-Thèrèse Leccia, Caroline Dutriaux, Henri Montaudié, Julie de Quatrebarbes, Thierry Lesimple, Florence Brunet-Possenti, Philippe Saiag, Julia Sanchez, Delphine Legoupil, Pierre-Emmanuel Stoebner, Jean Philippe Arnault, Wendy Lefevre, Celeste Lebbè, Olivier Dereure
Non-V600E/K BRAF Mutations in Metastatic Melanoma: Molecular Description, Frequency, and Effectiveness of Targeted Therapy in a Large National Cohort. JCO precision oncology 6 (2022)
Paolo Antonio Ascierto, Mario Mandala, Pier Francesco Ferrucci, Massimo Guidoboni, Piotr Lukasz Rutkowski, Virginia Ferraresi, Ana M Arance, Michele Guida, Evaristo Maiello, Helen J Gogas, Erika Richtig, Maria Teresa Fierro, Celeste Lebbè, Hildur Helgadottir, Paola Queirolo, Francesco Spagnolo, Marco Tucci, Michele Del Vecchio, Maria Gonzales Cao, Alessandro Marco Minisini, Sabino De Placido, Miguel F Sanmamed, Domenico Mallardo, Marcello Curvietto, Ignacio Melero, Giuseppe Palmieri, Antonio M Grimaldi, Diana Giannarelli, Reinhard Dummer, Vanna Chiarion Sileni
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF -Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Emmanuelle Kempf, Gérard Zalcman, Celeste Lebbè, null null
National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma? Cancer 127 (13) (2021)
Nader Yatim, Jeremy Boussier, Pauline Tetu, Nikaïa Smith, Timothee Bruel, Bruno Charbit, Laura Barnabei, Aurélien Corneau, Laetitia Da Meda, Clara Allayous, Barouyr Baroudjian, Majdi Jebali, Florian Herms, Ludivine Grzelak, Isabelle Staropoli, Vincent Calmettes, Jerome Hadjadj, Olivier Peyrony, Charles Cassius, Jérôme Le Goff, Nora Kramkimel, Selim Aractingi, Magnus Fontes, Catherine Blanc, Frédéric Rieux-Laucat, Olivier Schwartz, Benjamin Terrier, Darragh Duffy, Celeste Lebbè
Immune checkpoint inhibitors increase T cell immunity during SARS-CoV-2 infection. Science advances 7 (34) (2021)
Jedd D Wolchok, Vanna Chiarion Sileni, Rene Gonzalez, Jean-Jacques Grob, Piotr Lukasz Rutkowski, Christopher D Lao, C Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O Butler, Andrew Hill, Ivan Marquez-Rodas, John B A G Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S Carlino, Celeste Lebbè, Grant A McArthur, Paolo Antonio Ascierto, Gregory A Daniels, Georgina V Long, Tuba Bas, Corey Ritchings, James M G Larkin, Frank Stephen Hodi
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2021)
Bénédicte Oulès, Samia Mourah, Barouyr Baroudjian, Fanélie Jouenne, Julie Delyon, Baptiste Louveau, Aurélia Gruber, Celeste Lebbè, Maxime Battistella
Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK. Virchows Archiv : an international journal of pathology (2021)
Léa Dousset, Florence Poizeau, Caroline Robert, Sandrine Mansard, Laurent Mortier, Charline Caumont, Émilie Routier, Alain Dupuy, Jacques Rouanet, Maxime Battistella, Anna Greliak, David Cappellen, Marie-Dominique Galibert, Clara Allayous, Alexandra Lespagnol, Emilie Gérard, Inès Kerneuzet, Séverine Roy, Caroline Dutriaux, Jean-Philippe Merlio, Beatrice Vergier, Alexa B Schrock, Jessica Lee, Siraj M Ali, Solène-Florence Kammerer-Jacquet, Celeste Lebbè, Marie Beylot-Barry, Lise Boussemart
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy. JCO precision oncology 5 (2021)
Caroline Robert, Georgina V Long, Benjamin Brady, Caroline Dutriaux, Anna Maria Di Giacomo, Laurent Mortier, Piotr Rutkowski, Jessica C Hassel, Catriona M McNeil, Ewa Anna Kalinka, Celeste Lebbè, Julie Charles, Micaela M Hernberg, Kerry Joane Savage, Vanna Chiarion Sileni, Catalin Mihalcioiu, Cornelia Mauch, Ana Arance, Francesco Cognetti, Lars Ny, Henrik Schmidt, Dirk Schadendorf, Helen J Gogas, Jesús Zoco, Sandra Re, Paolo Antonio Ascierto, Victoria Atkinson
Five-Year Outcomes With Nivolumab in Patients With Wild-Type BRAF Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (33) (2020)
Barouyr Baroudjian, Dimitri Arangalage, Stefania Cuzzubbo, Baptiste Hervier, Celeste Lebbè, Gwenael Lorillon, Abdellatif Tazi, Gerard Zalcman, Mohamed Bouattour, Frédéric Lioté, Jean-François Gautier, Solenn Brosseau, Nelson Lourenco, Julie Delyon, null null
Management of immune-related adverse events resulting from immune checkpoint blockade. Expert review of anticancer therapy 19 (3) (2019)